1. Home
  2. INDP vs IVDA Comparison

INDP vs IVDA Comparison

Compare INDP & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • IVDA
  • Stock Information
  • Founded
  • INDP 2000
  • IVDA 2003
  • Country
  • INDP United States
  • IVDA United States
  • Employees
  • INDP N/A
  • IVDA N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • IVDA Computer Software: Prepackaged Software
  • Sector
  • INDP Health Care
  • IVDA Technology
  • Exchange
  • INDP Nasdaq
  • IVDA Nasdaq
  • Market Cap
  • INDP 10.2M
  • IVDA 9.3M
  • IPO Year
  • INDP N/A
  • IVDA N/A
  • Fundamental
  • Price
  • INDP $0.94
  • IVDA $3.17
  • Analyst Decision
  • INDP Strong Buy
  • IVDA
  • Analyst Count
  • INDP 2
  • IVDA 0
  • Target Price
  • INDP $8.50
  • IVDA N/A
  • AVG Volume (30 Days)
  • INDP 24.7K
  • IVDA 598.8K
  • Earning Date
  • INDP 11-12-2024
  • IVDA 11-14-2024
  • Dividend Yield
  • INDP N/A
  • IVDA N/A
  • EPS Growth
  • INDP N/A
  • IVDA N/A
  • EPS
  • INDP N/A
  • IVDA N/A
  • Revenue
  • INDP N/A
  • IVDA $5,305,155.00
  • Revenue This Year
  • INDP N/A
  • IVDA $23.76
  • Revenue Next Year
  • INDP N/A
  • IVDA $229.89
  • P/E Ratio
  • INDP N/A
  • IVDA N/A
  • Revenue Growth
  • INDP N/A
  • IVDA N/A
  • 52 Week Low
  • INDP $0.84
  • IVDA $1.27
  • 52 Week High
  • INDP $3.10
  • IVDA $10.16
  • Technical
  • Relative Strength Index (RSI)
  • INDP 34.68
  • IVDA 70.54
  • Support Level
  • INDP $0.94
  • IVDA $1.93
  • Resistance Level
  • INDP $1.06
  • IVDA $2.16
  • Average True Range (ATR)
  • INDP 0.05
  • IVDA 0.38
  • MACD
  • INDP 0.00
  • IVDA 0.14
  • Stochastic Oscillator
  • INDP 0.00
  • IVDA 65.45

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).

Share on Social Networks: